FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/06/2022
Back to search
Official data from USPTO
ANAPATH UNLIMITED PATHOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
06/06/2022
Trademark type
Combined
Nice classes
9, 42
Filing date
10/21/2020
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
11/30/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
ES
Examiner
RIBAUDO, MICHELLE
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ANAPATH" in blue stylized font with a white molecular atomic model outlined in blue placed in between the last "A" of "ANA" and the "P" of "PATH", all of which is above the wording "UNLIMITED PATHOLOGY" featured in blue stylized font.
Holders and representatives
Holders
VITRO, S.A.
Representatives
Lindy M. Herman Rutan & Tucker, LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Recorded and downloadable software for managing anatomical pathology laboratory data
Class 42
Scientific laboratory services; clinical research services in the field of pathology; medical research; development of computer software
Publications
History of USPTO decisions and trademark events.
21 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/17/2022
FIMP
FINAL DISPOSITION PROCESSED
05/17/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2021
RFNT
REFUSAL PROCESSED BY IB
04/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/05/2021
RFRR
REFUSAL PROCESSED BY MPU
04/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2021
CNRT
NON-FINAL ACTION WRITTEN
03/28/2021
DOCK
ASSIGNED TO EXAMINER
03/22/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/03/2020
Continuous trademark protection
Get notified about every new filing that threatens ANAPATH UNLIMITED PATHOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.